(Sharecast News) - Cambridge Nutritional Sciences said in an update on Wednesday that it expects lower full-year revenue and a swing to a small EBITDA loss for the year ended 31 March, reflecting disruption to orders in key international markets.
The AIM-traded diagnostics group said revenue is expected to be £7.0m,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE